We read with great interest the recent article by Fleurence and Chhatwal on implementing generative AI (GenAI) into Health Technology Assessment (HTA) practice (Reference Fleurence and Chhatwal1). The authors present a highly relevant framework, emphasizing that the readiness of GenAI is heavily task-dependent and should serve to augment, rather than replace, human expertise in bounded tasks.
This perspective strongly resonates with current challenges in clinical big data mining and the deployment of bedside AI. The authors correctly point out that GenAI excels in well-defined tasks such as systematic literature review screening and structured data extraction, yet struggles with fully autonomous, end-to-end reasoning. In the broader intersection of AI and medicine, particularly when analyzing complex clinical datasets, this distinction is crucial. While GenAI can rapidly process unstructured clinical text, deriving actionable, causal insights requires rigorous methodological constraints and human-in-the-loop accountability.
Furthermore, the article’s focus on transparent reporting and task-level validation—echoing the ISPOR ELEVATE-GenAI guidelines (Reference Fleurence, Dawoud, Bian, Higashi, Wang, Xu, Chhatwal and Ayer2)—is a necessary step toward building trust. In clinical applications, a model’s performance metrics are insufficient without clear documentation addressing its potential biases, calibration, and data governance. The authors’ warning regarding the legal implications of uploading unpublished or sensitive clinical data to third-party AI platforms is particularly salient. As we push toward integrating AI models into clinical workflows, establishing secure, localized processing environments will be as important as the algorithmic advancements themselves.
Ultimately, the successful integration of GenAI into both HTA and direct clinical practice depends on our ability to enforce rigorous evaluation standards while maintaining explicit human accountability for final decision-making. We commend the authors for providing a pragmatic, risk-based roadmap that helps bridge the gap between technical AI capabilities and methodological responsibility in healthcare.
Data availability
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Acknowledgements
None.
Author contribution
Zekai Yu: Formal Analysis, Investigation, Writing-Original Draft, Writing-Review & Editing.
Weihao Cheng: Formal Analysis, Writing-Original Draft, Writing-Review & Editing.
Feiwei Qin: Formal Analysis, Writing-Review & Editing.
Wei Xiong: Formal Analysis, Writing-Original Draft, Writing-Review & Editing.
Yang Hu: Formal Analysis, Writing-Review & Editing.
The author has read and agreed to the published version of the manuscript.
Funding statement
The authors declare that no external funding was received for this work.
Competing interests
We declare no competing interests.
Compliance with ethical standard
Research Involving Human Participants and/or Animals.
This research did not require the involvement of human or animal subjects. Therefore, ethical approval for this study was not required according to local regulations and institutional policies.
Informed consent
Not applicable.
Use of generative AI
During the preparation of this work the authors used Gemini 3.1 Pro and Claude Opus 4.6 to improve the readability and language quality of the manuscript. After using this tool the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.